FCN1 and Miyoshi myopathy: In the MM group, a marked drop in median ficolin-1 level (by ~30–40%) was observed in the sample taken after chemotherapy (immediately before HSCT) and a week later reached a minimum (often undetectable in sample 3) which was correlated with WBC count.